Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Serrano

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Cancers|April 13, 2024
Prognostic Value of <i>PCSK9</i> Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up StudyMassimiliano Ruscica, Chiara Macchi, Sara Gandini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2020
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breastMatteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, et al.
Biomedicines|June 28, 2023
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized TrialDavide Serrano, Federica Bellerba, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal womenAliana Guerrieri-Gonzaga, Chris Robertson, Bernardo Bonanni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2011
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trialAndrea Decensi, Matteo Puntoni, Giancarlo Pruneri, et al.
Cancer Metastasis Reviews|October 22, 2014
E-cadherin germline mutation carriers: clinical management and genetic implicationsGiovanni Corso, Joana Figueiredo, Roberto Biffi, et al.
Cancers|October 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) StudySilvia Polidoro, Harriet Johansson, Giovanni Cugliari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancerDebora Macis, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 13, 2017
A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast CancerMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Cancers|April 13, 2024
Prognostic Value of <i>PCSK9</i> Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up StudyMassimiliano Ruscica, Chiara Macchi, Sara Gandini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2020
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breastMatteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, et al.
Biomedicines|June 28, 2023
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized TrialDavide Serrano, Federica Bellerba, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal womenAliana Guerrieri-Gonzaga, Chris Robertson, Bernardo Bonanni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2011
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trialAndrea Decensi, Matteo Puntoni, Giancarlo Pruneri, et al.
Cancer Metastasis Reviews|October 22, 2014
E-cadherin germline mutation carriers: clinical management and genetic implicationsGiovanni Corso, Joana Figueiredo, Roberto Biffi, et al.
Cancers|October 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) StudySilvia Polidoro, Harriet Johansson, Giovanni Cugliari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancerDebora Macis, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 13, 2017
A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast CancerMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Pageof 9